1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ASTRAZENECA PLC - ADR
Astrazeneca plc - ADR XNAS: AZN

Astrazeneca plc - ADR Live Stock Price Today, Share Analysis and Chart

Turnaround Potential
about

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and m...

Read More
79.90 -0.09 (-0.11%)
30.47% Gain from 52W Low
2.8M
XNAS Volume

XNAS 29 Aug, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Astrazeneca plc - ADR is on 10 Sep 2025 for the purpose of Conference, Kepler Cheuvreux Flagship Autumn Conference, Paris [IR] 2025 See details
Durability score
Medium Financial Strength
50.0 / 100
Valuation Score
Mid Valuation
31.8 / 100
Momentum Score
Technically Moderately Bullish
63.8 / 100
Turnaround Potential These stocks may be affordable or expensive due to their medium quality and a good technical scoring. However, their reasonable financials successfully attract investors. View Similar Embed DVM
Analyst Price Target
87
1Yr Price target upside is 8%
11 analysts

16

S

6

W

0

O

3

T

SWOT Analysis

Astrazeneca plc - ADR Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..